Dependency control
A directed acyclic graph records upstream producers and required releases.
Resources · Methods
Methods that travel
with their evidence.
Reusable platform mechanisms keep project hypotheses separate while standardizing provenance, validation, and release boundaries.
Platform methods
Reproducibility is an architectural property.
These are platform contracts, not claims that any current scaffold has completed the lifecycle.
Dataset lineage
RAW, CURATED, and PROJECT layers keep source, shared, and derived data distinct.
Typed artifacts
Schema versions, checksums, producers, and provenance travel with outputs.
Validation gates
Shared G0–G7 states separate configuration, analysis, evaluation, and approval.
Validation lifecycle
Eight visible gates to an approved release.
Projects may add stricter checks, but they may not silently bypass shared gates.
- G0Configuration valid
- G1Inputs available
- G2Data QC passed
- G3Analysis complete
- G4Internal validation complete
- G5External validation evaluated
- G6Robustness evaluated
- G7Release approved
Registered schemas
Typed scientific artifact contracts.
CandidateVulnerability
Schema 1.0.0
DrugResponse
Schema 1.0.0
DrugResponseEvidence
Schema 1.0.0
FeatureEvidence
Schema 1.0.0
FeatureEvidence
Schema 2.0.0
FunctionalDependency
Schema 1.0.0
GeneAssociation
Schema 1.0.0
MolecularSignature
Schema 1.0.0
MolecularSignature
Schema 2.0.0
MolecularStatePrediction
Schema 1.0.0
PathwayActivity
Schema 1.0.0
ProteinAssociation
Schema 1.0.0
ProteinValidationEvidence
Schema 1.0.0
SubtypePrediction
Schema 1.0.0